The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive ...
Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...
6d
GlobalData on MSNEMA recommends Bavarian Nordic’s chikungunya vaccine for adults and teenagersIf authorised, Vimkunya would be the first vaccine in the EU to protect adolescents aged 12 to 17 against Chikungunya.
For now, her focus is on making the most of its existing portfolio, notably Keytruda – the world’s top-selling cancer drug – ...
2d
GlobalData on MSNItalian charity seeks EMA approval for rescued gene therapyTelethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.
In the latest development, the European Commission has asked the EMA's human medicines committee, the CHMP, to take a look at ...
The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...
Ocugen (OCGN) announced that the European Commission has provided a positive opinion from the EMA’s, or European Medicines Agency’s, Committee ...
AstraZeneca (AZN) stock in focus as its partner Daiichi Sankyo (DSNKY) wins EU backing for their jointly developed breast ...
AUD/USD extends its consolidative price move and remains below the 0.6300 mark on Friday amid mixed cues. Bets that the RBA ...
EU agencies unite to tackle azole fungicide resistance in Aspergillus fungi: Amsterdam, The Netherlands Monday, February 3, 2025, 17:00 Hrs [IST] For the first time, t ...
Ocugen (OCGN) said it has received a positive opinion from EU regulators for Advanced Therapy Medicinal Product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results